Defining the role of anti-and pro-inflammatory outcomes of interleukin-6 in mental health

M García-Juárez, A Camacho-Morales - Neuroscience, 2022 - Elsevier
Abstract Interleukin-6 (IL-6) is a major cytokine that promotes anti-and pro-inflammatory
outcomes by activating the membrane IL-6 receptor (IL-6R) or the soluble IL-6 receptor (sIL …

Progress in treatment of Neuromyelitis Optica Spectrum Disorders (NMOSD): Novel insights into therapeutic possibilities in NMOSD

M Shi, F Chu, T Jin, J Zhu - CNS Neuroscience & Therapeutics, 2022 - Wiley Online Library
Neuromyelitis optica spectrum disorder (NMOSD) is a rare autoimmune inflammatory
demyelinating disorder of the central nervous system (CNS), which is a severely disabling …

ATH17-intrinsic IL-1β–STAT5 axis drives steroid resistance in autoimmune neuroinflammation

WA Miller-Little, X Chen, V Salazar, C Liu, K Bulek… - Science …, 2024 - science.org
Steroid resistance poses a major challenge for the management of autoimmune
neuroinflammation. T helper 17 (TH17) cells are widely implicated in the pathology of steroid …

Role of toll-like receptors in neuroimmune diseases: Therapeutic targets and problems

H Li, S Liu, J Han, S Li, X Gao, M Wang, J Zhu… - Frontiers in …, 2021 - frontiersin.org
Toll-like receptors (TLRs) are a class of proteins playing a key role in innate and adaptive
immune responses. TLRs are involved in the development and progression of neuroimmune …

[HTML][HTML] The gut microbiome in neuromyelitis optica

SS Zamvil, CM Spencer, SE Baranzini, BAC Cree - Neurotherapeutics, 2018 - Elsevier
Neuromyelitis optica (NMO) is a rare, disabling, sometimes fatal central nervous system
inflammatory demyelinating disease that is associated with antibodies (“NMO IgG”) that …

Proportions of Th17 cells and Th17-related cytokines in neuromyelitis optica spectrum disorders patients: a meta-analysis

MM Hou, YF Li, LL He, XQ Li, Y Zhang… - International …, 2019 - Elsevier
Background T helper (Th17) cells play an important role in many autoimmune diseases. In
this meta-analysis, we aimed to specify the proportion of Th17 cells and the levels of Th17 …

Discrepancy in clinical and laboratory profiles of NMOSD patients between AQP4 antibody positive and negative: can NMOSD be diagnosed without AQP4 antibody?

F Chu, M Shi, C Liu, J Zhu - Clinical and Experimental …, 2023 - academic.oup.com
AQP4-IgG has been considered as the pathogenic factor leading to NMOSD. However,
about 20–30% of patients lack AQP4-IgG. So far, all therapeutic medicines are ineffective for …

Elevated proportion of TLR2-and TLR4-expressing Th17-like cells and activated memory B cells was associated with clinical activity of cerebral cavernous …

C Castro, HAA Oyamada, MOSD Cafasso… - Journal of …, 2022 - Springer
Background Recent evidences have suggested the involvement of toll-like receptor (TLR)-4
in the pathogenesis of cerebral cavernous malformations (CCM). Elevated frequency of …

Different interleukin‐17‐secreting Toll‐like receptor+ T‐cell subsets are associated with disease activity in multiple sclerosis

TB Ferreira, J Hygino, AC Wing, TM Kasahara… - …, 2018 - Wiley Online Library
Signalling through Toll‐like receptors (TLRs) may play a role in the pathogenesis of
autoimmune diseases, such as multiple sclerosis (MS). In the present study, the expression …

TLR-2 and TLR-4 agonists favor expansion of CD4+ T cell subsets implicated in the severity of neuromyelitis optica spectrum disorders

ASO Dias, PM Sacramento, LM Lopes… - Multiple Sclerosis and …, 2019 - Elsevier
Abtstact Background High frequency of circulating Th17 cell subsets expressing TLR2, TLR4
and TLR9 was observed in Neuromyelitis optica spectrum disorder (NMOSD) patients, a …